Abstract GS1-11: Sacituzumab Govitecan (SG) vs Treatment of Physician’s Choice (TPC): Efficacy by Trop-2 Expression in the TROPiCS-02 Study of Patients (Pts) With HR+/HER2-Metastatic Breast Cancer (mBC). San Antonio Breast Cancer Symposium 2022 - Rugo, H S; Bardia, A; Marmé, F (Cancer Res, 2023)
et al.